1-1banner
 
medpundit
 

 
Commentary on medical news by a practicing physician.
 

 
Google
  • Epocrates MedSearch Drug Lookup




  • MASTER BLOGS





    "When many cures are offered for a disease, it means the disease is not curable" -Anton Chekhov




    ''Once you tell people there's a cure for something, the more likely they are to pressure doctors to prescribe it.''
    -Robert Ehrlich, drug advertising executive.




    "Opinions are like sphincters, everyone has one." - Chris Rangel



    email: medpundit-at-ameritech.net

    or if that doesn't work try:

    medpundit-at-en.com



    Medpundit RSS


    Quirky Museums and Fun Stuff


    Who is medpundit?


    Tech Central Station Columns



    Book Reviews:
    Read the Review

    Read the Review

    Read the Review

    More Reviews

    Second Hand Book Reviews

    Review


    Medical Blogs

    rangelMD

    DB's Medical Rants

    Family Medicine Notes

    Grunt Doc

    richard[WINTERS]

    code:theWebSocket

    Psychscape

    Code Blog: Tales of a Nurse

    Feet First

    Tales of Hoffman

    The Eyes Have It

    medmusings

    SOAP Notes

    Obels

    Cut-to -Cure

    Black Triangle

    CodeBlueBlog

    Medlogs

    Kevin, M.D

    The Lingual Nerve

    Galen's Log

    EchoJournal

    Shrinkette

    Doctor Mental

    Blogborygmi

    JournalClub

    Finestkind Clinic and Fish Market

    The Examining Room of Dr. Charles

    Chronicles of a Medical Mad House

    .PARALLEL UNIVERSES.

    SoundPractice

    Medgadget
    Health Facts and Fears

    Health Policy Blogs

    The Health Care Blog

    HealthLawProf Blog

    Facts & Fears

    Personal Favorites

    The Glittering Eye

    Day by Day

    BioEdge

    The Business Word Inc.

    Point of Law

    In the Pipeline

    Cronaca

    Tim Blair

    Jane Galt

    The Truth Laid Bear

    Jim Miller

    No Watermelons Allowed

    Winds of Change

    Science Blog

    A Chequer-Board of Night and Days

    Arts & Letters Daily

    Tech Central Station

    Blogcritics

    Overlawyered.com

    Quackwatch

    Junkscience

    The Skeptic's Dictionary



    Recommended Reading

    The Doctor Stories by William Carlos Williams


    Pox Americana: The Great Smallpox Epidemic of 1775-82 by Elizabeth Fenn


    Intoxicated by My Illness by Anatole Broyard


    Raising the Dead by Richard Selzer


    Autobiography of a Face by Lucy Grealy


    The Man Who Mistook His Wife for a Hat by Oliver Sacks


    The Sea and Poison by Shusaku Endo


    A Midwife's Tale by Laurel Thatcher Ulrich




    MEDICAL LINKS

    familydoctor.org

    American Academy of Pediatrics

    General Health Info

    Travel Advice from the CDC

    NIH Medical Library Info

     



    button

    Friday, August 08, 2003

    Wonder Drugs No More: This must be the beginning of the end of the era of Prozac. It's no longer the darling of the media, which in the past, has portrayed it as a safe as candy, miraculous happiness pill. The New York Times has turned on it and its relations. They are, it seems, deathtraps:

    Warnings by drug regulators about the safety of Paxil, one of the world's most prescribed antidepressants, are reopening seemingly settled questions about a whole class of drugs that also includes Prozac and Zoloft.

    ...And the findings have unsettled some of the very experts who absolved S.S.R.I.'s of a link to suicide a dozen years ago. Of the 10 American specialists who, as members of an ad hoc F.D.A. panel, formally cleared the drugs of a link to suicide in 1991, seven now say that the new information would prompt them to reconsider that decision, if they were asked.

    "In 1991, we said there wasn't sufficient evidence to support a link between these drugs and suicide," said Dr. Jeffrey A. Lieberman, a professor of psychiatry and pharmacology at the University of North Carolina and a member of the panel. "Now there is evidence, at least in children, and I wouldn't rule out that it's in adults, too."


    The furor has been set off by an analysis of unpublished studies by the British version of the FDA:

    The British regulators said that their analysis of the nine studies of Paxil found 3.2 times the likelihood of suicidal thoughts or suicide attempts among teens and children given the drug as among patients given a placebo. They also said that Paxil has not proved effective against depression in children and teenagers.

    The British regulator’s announcement is here, but it doesn’t shed any more light on the subject than the Times article. The evidence that these drugs increase the risk of suicide is sparse. In fact, it’s more than sparse. It’s unpublished and unavailable except to the regulators.

    The Medical Letter, an excellent, unbiased source of drug information, reviewed the subject last month and found the evidence wanting. According to The Letter, the FDC Reports cited a study that found among 1,134 children, “emotional lability” occurred in 3.2% of users compared to 1.5% of nonusers. “Emotional lability” was defined as “crying, mood fluctuations, thoughts of suicide and attempted suicide.” There were no completed suicides in the group. That's an important distinction. It isn't uncommon for depressed people, especially teenagers, to make a consciously feeble attempt at suicide - such as taking a drug they think is harmless, like Tylenol. Their goal isn't to kill themselves, but to gain attention.

    On the face of it, the current recommendation to avoid these drugs seems overly cautious. For one thing, compared to older anti-depressants, they are more effective and they are safer. In the old days, before SSRI’s, doctors always excercised caution with anti-depressants because the drugs themselves could be instruments of suicide. Patients would only be given a small amount of the drugs at a time, say a week or two, to avoid intentional overdoses. With the SSRI’s, that’s not a problem.

    The other suspicious aspect of the findings is that the suicide risk is highest in the first few weeks of the drug’s use. Paxil takes three or four weeks to work. Might it not be the case that the suicide risk is highest in those first few weeks not because of the drug but because the depression isn't yet fully treated?

    And Another Thing: Have you ever noticed that the New York Times has a bias against primary care physicians, especially family physicians? This is the second time in as many months that they’ve insinuated that primary care physicians - specifically family physicians - don’t know how to treat depression. The last time, their interview subject had to make a public apology, although The Times never did.

    UPDATE: Or maybe the suicide rate in the first few weeks of treatment is due to the success of the treatment, as this reader points out:

    There's an interesting theory about why SSRIs may actually lead to suicide in some cases that I, as a depression sufferer myself (treatable, thank god) find quite rational. When you are really depressed, you can barely get out of bed. Sometimes you just curl up in a ball. The very idea of leaving the house fills you with dread. In that state, you don't want to be alive but going through the motions of committing suicide is far beyond your capabilities. However, let's say you start an anti-depressant and START to feel better but insofar as recovery is slow you're far from feeling the full effect of the drug. During that short window of generally a few weeks you may get just enough recovery to kill yourself. That is, you're recovering but you don't realize it yet. You just realize that at last you have the ability to realize your fantasy of being dead. I'm sure the day will come when we have pills or some other therapy that will knock out depression in a day. But until then, I think the possibility of the occasional suicide as opposed to a lifetime of depression is a highly acceptable trade-off. Deep depression is death anyway.

    Good point.
     

    posted by Sydney on 8/08/2003 08:44:00 AM 0 comments

    0 Comments:

    Post a Comment

    This page is powered by Blogger, the easy way to update your web site.

    Main Page

    Ads

    Home   |   Archives

    Copyright 2006